Literature DB >> 279584

Identification of C3a, IgG, IgM in inflamed human gingiva.

P D Toto, L Lin, A Gargiulo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 279584     DOI： 10.1177/00220345780570050501

Source DB:  PubMed          Journal:  J Dent Res        ISSN： 0022-0345            Impact factor:   6.116


× No keyword cloud information.
  10 in total

Review 1.  Revisiting the Page & Schroeder model: the good, the bad and the unknowns in the periodontal host response 40 years later.

Authors:  George Hajishengallis; Jonathan M Korostoff
Journal:  Periodontol 2000       Date:  2017-10       Impact factor: 7.589

Review 2.  Complement and periodontitis.

Authors:  George Hajishengallis
Journal:  Biochem Pharmacol       Date:  2010-06-23       Impact factor: 5.858

3.  Inhibition of pre-existing natural periodontitis in non-human primates by a locally administered peptide inhibitor of complement C3.

Authors:  Tomoki Maekawa; Ruel A Briones; Ranillo R G Resuello; Joel V Tuplano; Evlambia Hajishengallis; Tetsuhiro Kajikawa; Sophia Koutsogiannaki; Cristina A G Garcia; Daniel Ricklin; John D Lambris; George Hajishengallis
Journal:  J Clin Periodontol       Date:  2016-03-03       Impact factor: 8.728

Review 4.  Role of complement in host-microbe homeostasis of the periodontium.

Authors:  George Hajishengallis; Toshiharu Abe; Tomoki Maekawa; Evlambia Hajishengallis; John D Lambris
Journal:  Semin Immunol       Date:  2013-05-16       Impact factor: 11.130

Review 5.  Complement therapeutics in inflammatory diseases: promising drug candidates for C3-targeted intervention.

Authors:  D C Mastellos; D Ricklin; E Hajishengallis; G Hajishengallis; J D Lambris
Journal:  Mol Oral Microbiol       Date:  2015-10-07       Impact factor: 3.563

Review 6.  Complement Involvement in Periodontitis: Molecular Mechanisms and Rational Therapeutic Approaches.

Authors:  George Hajishengallis; Tomoki Maekawa; Toshiharu Abe; Evlambia Hajishengallis; John D Lambris
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

Review 7.  Complement inhibition in pre-clinical models of periodontitis and prospects for clinical application.

Authors:  George Hajishengallis; Evlambia Hajishengallis; Tetsuhiro Kajikawa; Baomei Wang; Despina Yancopoulou; Daniel Ricklin; John D Lambris
Journal:  Semin Immunol       Date:  2016-03-24       Impact factor: 11.130

8.  Safety and Efficacy of the Complement Inhibitor AMY-101 in a Natural Model of Periodontitis in Non-human Primates.

Authors:  Tetsuhiro Kajikawa; Ruel A Briones; Ranillo R G Resuello; Joel V Tuplano; Edimara S Reis; Evlambia Hajishengallis; Cristina A G Garcia; Despina Yancopoulou; John D Lambris; George Hajishengallis
Journal:  Mol Ther Methods Clin Dev       Date:  2017-08-18       Impact factor: 6.698

Review 9.  Complement-Dependent Mechanisms and Interventions in Periodontal Disease.

Authors:  George Hajishengallis; Tetsuhiro Kajikawa; Evlambia Hajishengallis; Tomoki Maekawa; Edimara S Reis; Dimitrios C Mastellos; Despina Yancopoulou; Hatice Hasturk; John D Lambris
Journal:  Front Immunol       Date:  2019-03-12       Impact factor: 7.561

10.  Complement split product C3c in saliva as biomarker for periodontitis and response to periodontal treatment.

Authors:  Maria Anastasia Grande; Daniel Belstrøm; Christian Damgaard; Palle Holmstrup; Sai Sindhu Thangaraj; Claus Henrik Nielsen; Yaseelan Palarasah
Journal:  J Periodontal Res       Date:  2020-07-18       Impact factor: 4.419
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.